ARCHIVES

FDA Advisors Debate Ban, Black Box And Status Quo of Power Morcellators

This article is from The Cancer Letter archive.

Vol. 40 No. 30 | July 25, 2014

Download PDF Visit The Full Archive

Related Articles

FDA Approves Aranesp For Chemo-Induced Anemia

August 30, 2002

Some Children With Hodgkin’s Disease Can Reduce Or Skip Radiation, Study Finds

October 29, 2004

NCI Names Brawly Director of Office of Special Populations

June 21, 1996

In Brief: FDA Oncology Div. Director Burke To Leave; Reed Is Branch Chief; NCAB Blasts Tobacco

November 4, 1994

FDA Approves Large-Volume Processor For Cytyc’s ThinPrep Pap Test Samples.

June 30, 2000

New Organ Systems Concept Flow Discussed

October 18, 1985